KIM HAM: Open Payments
NPI 1417377540 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 63 payments from 17 companies in 2025. Trend: 2023 $1,228 · 2024 $1,499 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 7 | $273 |
| ABBVIE INC. | 8 | $167 |
| Otsuka America Pharmaceutical, Inc. | 9 | $162 |
| Lundbeck LLC | 8 | $147 |
| Alexion Pharmaceuticals, Inc. | 6 | $143 |
| PFIZER INC. | 6 | $116 |
| Lilly USA, LLC | 5 | $111 |
| Janssen Biotech, Inc. | 4 | $81 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| ACADIA Pharmaceuticals Inc | 1 | $27 |
Products named: Leqembi, REXULTI, ULTOMIRIS, NURTEC ODT, KISUNLA, QULIPTA, UBRELVY, VYEPTI.
Industry payments across NY — which companies pay providers there.
